Literature DB >> 2968247

Risk factors for stroke in chronic atrial fibrillation.

P Petersen1, J Godtfredsen.   

Abstract

Atrial fibrillation is associated with an increased risk of stroke. Different risk factors may be of importance regarding stroke incidence and mortality in atrial fibrillation. Retrospectively, we studied 786 patients with chronic atrial fibrillation, 229 with rheumatic heart disease and 557 without. In all, 127 patients had stroke (16%). Using Cox's proportional hazard model for failure-time data with age, gender, etiology, degree of heart failure and cardiac enlargement as explanatory (independent) variables, only etiology (rheumatic heart disease) was a significant risk factor for stroke (P less than 0.006). Significant risk factors for death in 653 patients without stroke were age (P = 0.000) and congestive heart failure at the onset of atrial fibrillation (P = 0.000). The need to identify other risk factors for stroke in patients with atrial fibrillation is emphasized, for selecting patients at high risk for prophylactic treatment with anticoagulants or aspirin.

Entities:  

Mesh:

Year:  1988        PMID: 2968247     DOI: 10.1093/oxfordjournals.eurheartj.a062499

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

Review 1.  Amiodarone as a first-line drug in the treatment of atrial fibrillation: the protagonist viewpoint.

Authors:  S Lévy
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 2.  Long-term anticoagulation. Indications and management.

Authors:  B M Stults; W H Dere; T H Caine
Journal:  West J Med       Date:  1989-10

Review 3.  Surgical perspectives in the management of atrial fibrillation.

Authors:  Katerina Kyprianou; Agamemnon Pericleous; Antonio Stavrou; Inetzi A Dimitrakaki; Dimitrios Challoumas; Georgios Dimitrakakis
Journal:  World J Cardiol       Date:  2016-01-26

4.  The New 3D Printed Left Atrial Appendage Closure with a Novel Holdfast Device: A Pre-Clinical Feasibility Animal Study.

Authors:  M Brzeziński; K Bury; L Dąbrowski; P Holak; A Sejda; M Pawlak; D Jagielak; Z Adamiak; J Rogowski
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.